The American investment company Apollo Global Management Inc. is negotiating the acquisition of the orthopedic division of Johnson&Johnson (J&J) as part of the company's restructuring. This is reported by foreign media.
The value of DePuy Synthes is estimated at $20 billion or $28 billion, including debt obligations. At the same time, J&J's market capitalization is $640 billion, and the market value of Apollo is $76 billion.
In October 2025, J&J announced plans to spin off the orthopedic business into a separate company. The proposed sale has attracted several private investment companies that may join together to participate in the tender in mid-2027.
The acquisition of DePuy Synthes will allow Apollo to make significant investments in a stable asset and will be Apollo's largest investment in the healthcare sector.
As a result of the deal, DePuy Synthes will become the world's largest orthopedic company manufacturing hip and knee replacement devices while maintaining its independent status. In 2025, revenue amounted to $9.3 billion.
Johnson&Johnson is an American manufacturer of medicines and medical equipment. The company includes divisions of innovative medicine and medical technologies for various therapeutic areas (oncology, immunology, neurology, treatment of infectious and cardiovascular diseases, etc.). The headquarters is located in New Brunswick (New Jersey).
Apollo Global Management is an American alternative asset management investment company. The company provides a wide range of services, including asset management in income, hybrid and stock markets, as well as pension services. First of all, the company serves the financial sector. The headquarters is located in New York (USA). Apollo Global manages assets worth $840 billion, including $392 billion in loans.
Read our Telegram channel "Mergers and acquisitions. AK&M».
Our channel at MAX is "Mergers and Acquisitions. AK&M»
